J. Hall

发表

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

D. Teachey, C. Sheen, J. Hall, 2008, Blood.

Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies

U. McDermott, M. Garnett, C. Benes, 2018, Cell cycle.

Targeting Notch signaling in autoimmune and lymphoproliferative disease.

D. Teachey, C. Sheen, J. Hall, 2008, Blood.

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

K. Sullivan, J. Maris, D. Teachey, 2006, Blood.

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.

M. Loh, D. Teachey, C. Sheen, 2012, Blood.

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

M. Loh, D. Teachey, J. Hall, 2015, Blood.

Targeting JAK 1 / 2 and mTOR in Murine Xenograft Models of Ph-like Acute Lymphoblastic Leukemia ( ALL )

M. Loh, D. Teachey, C. Sheen, 2012 .